CN Patent

CN105693556A — 卡巴拉汀酒石酸盐的转化方法及其产物制成的贴片

Assigned to Parsd Medical Technology (changzhou) Co Ltd · Expires 2016-06-22 · 10y expired

What this patent protects

本发明涉及经皮传输技术领域，尤其是一种卡巴拉汀酒石酸盐的转化方法及其产物制成的贴片。加入卡巴拉汀酒石酸盐相同摩尔数的无机碱或有机碱，将卡巴拉汀酒石酸盐转化成卡巴拉汀游离碱和酒石酸；这种转化过程，可在贴片内或是在贴片外形成。采用转化产物制成的三层或四层的贴片，分别为背面保护层、含药和皮肤贴附层、和释放衬垫，或还设有卡巴拉汀控释和皮肤贴附层。本发明可实现卡巴拉汀48小时等速的经皮传输，48小时恒定的血液浓度。

USPTO Abstract

本发明涉及经皮传输技术领域，尤其是一种卡巴拉汀酒石酸盐的转化方法及其产物制成的贴片。加入卡巴拉汀酒石酸盐相同摩尔数的无机碱或有机碱，将卡巴拉汀酒石酸盐转化成卡巴拉汀游离碱和酒石酸；这种转化过程，可在贴片内或是在贴片外形成。采用转化产物制成的三层或四层的贴片，分别为背面保护层、含药和皮肤贴附层、和释放衬垫，或还设有卡巴拉汀控释和皮肤贴附层。本发明可实现卡巴拉汀48小时等速的经皮传输，48小时恒定的血液浓度。

Drugs covered by this patent

Patent Metadata

Patent number
CN105693556A
Jurisdiction
CN
Classification
—
Expires
2016-06-22
Drug substance claim
No
Drug product claim
No
Assignee
Parsd Medical Technology (changzhou) Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.